Friends! In this video, I'm going to do an analysis on Paypal stock, BMY stock and TGT stock

AI-generated source summary

The video provides a fundamental analysis of three stocks: PayPal (PYPL), Bristol-Myers Squibb (BMY), and Target (TGT).For PYPL, the analysis notes a 61% decline over five years, indicating a long base formation, and growing active accounts. Despite revenue growth deceleration, it's accelerating. With $7B in free cash flow and significant share buybacks, the analyst infers a target price of $100. The analysis will be invalidated at $60.BMY trades at seven times earnings with a sustainable dividend yield. Despite impending patent expirations, the video highlights BMY’s strategy of acquiring new drugs to maintain free cash flow. It is assigned a target of $60 and fail price of $40.Target's comp sales have been negative and depend greatly on discretionary expenditures, resulting in a negative outlook. The analysis will be invalidated at a price of $95, with an inferred target of $70.

AI-generated summary based on the source content.

Evidence and evaluation progress

1. Original source published

   20 Sept 2025, 19:29 UTC

   The analyst published the original source item.

2. First prediction resolved

   23 Oct 2025, 13:30 UTC

   The first evaluable outcome in this case reached a terminal result.

3. Source recorded by Tahlil Plus

   18 May 2026, 20:23 UTC

   The public source was preserved as the evidence record for this case.

4. Market predictions extracted

   18 May 2026, 20:47 UTC

   3 eligible signals linked to this case.

5. Outcome tracking started

   02 Jul 2026, 01:22 UTC

   Tahlil Plus began monitoring the extracted predictions.

6. Case evaluation completed

   02 Jul 2026, 01:22 UTC

   All evaluable predictions in this case reached terminal outcomes.